P Larochelle
Overview
Explore the profile of P Larochelle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
836
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Larochelle P, Kollmannsberger C, Feldman R, Schiffrin E, Poirier L, Patenaude F, et al.
Curr Oncol
. 2012 Aug;
19(4):202-8.
PMID: 22876146
Inhibitors of the vascular endothelial growth factor (vegf-is) signalling pathway have fundamentally changed the treatment of metastatic renal cell carcinoma (mrcc). Hypertension is one of the most common side effects...
2.
Gabrielse G, Larochelle P, Le Sage D, Levitt B, Kolthammer W, McConnell R, et al.
Phys Rev Lett
. 2008 Jun;
100(11):113001.
PMID: 18517780
Slow antihydrogen (H) is produced within a Penning trap that is located within a quadrupole Ioffe trap, the latter intended to ultimately confine extremely cold, ground-state H[over ] atoms. Observed...
3.
Gabrielse G, Larochelle P, Le Sage D, Levitt B, Kolthammer W, Kuljanishvili I, et al.
Phys Rev Lett
. 2007 May;
98(11):113002.
PMID: 17501048
Antiprotons (p[over]) remain confined in a Penning trap, in sufficient numbers to form antihydrogen (H[over ) atoms via charge exchange, when the radial field of a quadrupole Ioffe trap is...
4.
Zanchetti A, Hansson L, Dahlof B, Elmfeldt D, Kjeldsen S, Kolloch R, et al.
J Hypertens
. 2001 Jun;
19(6):1149-59.
PMID: 11403365
Background: The Hypertension Optimal Treatment (HOT) Study has provided information about cardiovascular events in 18790 hypertensives, subjected to pronounced blood pressure (BP) lowering for a mean of 3.8 years. The...
5.
Tamblyn R, Laprise R, Hanley J, Abrahamowicz M, Scott S, Mayo N, et al.
JAMA
. 2001 Mar;
285(4):421-9.
PMID: 11242426
Context: Rising costs of medications and inequities in access have sparked calls for drug policy reform in the United States and Canada. Control of drug expenditures by prescription cost-sharing for...
6.
Lambert R, van Nguyen P, Cusson J, Wistaff R, Larochelle P
Arch Mal Coeur Vaiss
. 2000 Sep;
93(8):919-24.
PMID: 10989730
Unlabelled: Diltiazem tends to decrease proteinuria in hypertensive diabetic subjects in comparison to amlodipine that does not modify it. Since estimated glomerular pressure is identical in amlodipine treated and diltiazem...
7.
Feldman R, Campbell N, Larochelle P
Lancet
. 2000 Sep;
356(9228):509.
PMID: 10981916
No abstract available.
8.
Pausova Z, Deslauriers B, Gaudet D, Tremblay J, Kotchen T, Larochelle P, et al.
Hypertension
. 2000 Jul;
36(1):14-9.
PMID: 10904006
Obesity represents a serious risk factor for the development of cardiovascular diseases, including hypertension. Segregation studies suggest that obesity and obesity-associated hypertension may share some genetic determinants. The results of...
9.
Orlov S, Pausova Z, Gossard F, Gaudet D, Tremblay J, Kotchen T, et al.
J Hypertens
. 2000 Mar;
17(12 Pt 2):1859-65.
PMID: 10703881
Objectives: Erythrocyte Na+/Li+ countertransport and Na+,K+ cotransport are increased in some Caucasians with essential hypertension. This study examines the relative contributions of genetic and shared environmental factors to the activity...
10.
Feldman R, Campbell N, Larochelle P
CMAJ
. 2000 Jan;
161 Suppl 12:S18-22.
PMID: 10624418
The 1999 Canadian Recommendations for the Management of Hypertension are notable for the trends that they represent with regard to the evolution of the management of hypertension. Diagnostically, the Recommendations...